| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 2.327 | 1.653 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | - | 2.327 | 1.653 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | - | 419 | 203 | 210 | 101 | 99 | 0 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | - | 1.908 | 1.450 | -210 | -101 | -99 | 0 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | - | 1.838 | 1.402 | -210 | -101 | -99 | 0 | 0 | 0 | 0 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Phe Daniela Diagnostic Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 811 | 692 | 576 | 464 | 356 | 348 | 349 | 348 | 346 |
| Current Assets | - | 2.394 | 4.063 | 3.936 | 3.860 | 3.787 | 3.703 | 3.714 | 3.703 | 3.682 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 1.653 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | - | 2.394 | 2.410 | 3.936 | 3.860 | 3.787 | 3.703 | 3.714 | 3.703 | 3.682 |
| Shareholders Funds | - | 1.927 | 3.296 | 3.025 | 2.866 | 2.712 | 2.652 | 2.660 | 2.652 | 2.638 |
| Social Capital | - | 89 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | - | 1.277 | 1.458 | 1.486 | 1.457 | 1.430 | 1.398 | 1.402 | 1.398 | 1.390 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Phe Daniela Diagnostic Srl